OQROGet OQRO Pro
Insider trade

Labcorp (LH)Officer sold ~$453K

van der Vaart Sandra D, Officer at Labcorp, sold ~$453K of Labcorp shares.

~$453K
Approx. value · 1,900 sh @ $238.36
2,243.54
Holds after · shares reported
Traded
May 1, 2025
Filed
May 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 5, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  2. Feb 8, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  3. Feb 17, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  4. Feb 25, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  5. Feb 27, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  6. Feb 28, 2025InsiderOfficer sold ~$1.33M of LH shares in the open market
  7. Feb 28, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  8. Mar 5, 2025InsiderDirector sold ~$128K of LH shares in the open market
  9. Mar 28, 2025Insider · 2 peopleInsiders: 2 sales (~$786K)
  10. Mar 31, 2025CongressDisclosed partial sale of LH — reported range $1,001 - $15,000
  11. Apr 8, 2025CongressDisclosed sale of LH — reported range $1,001 - $15,000
  12. May 1, 2025 · this disclosureInsiderOfficer sold ~$453K of LH shares in the open market

What came next

  1. May 1, 2025InsiderOfficer sold ~$201K of LH shares in the open market
  2. May 12, 2025InsiderCEO sold ~$1.52M of LH shares in the open market
  3. May 15, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  4. Jun 3, 2025InsiderOfficer sold ~$494K of LH shares in the open market
  5. Jun 11, 2025InsiderDirector sold ~$130K of LH shares in the open market
  6. Jul 1, 2025InsiderDirector sold ~$133K of LH shares in the open market
  7. Jul 24, 2025InsiderDirector sold ~$980K of LH shares in the open market
  8. Jul 29, 2025Insider · 1 personInsiders: 2 sales (~$53K)
  9. Jul 30, 2025InsiderDirector sold ~$530K of LH shares in the open market
  10. Aug 11, 2025InsiderCEO sold ~$1.51M of LH shares in the open market
  11. Aug 13, 2025InsiderOfficer sold ~$1.06M of LH shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Labcorp

For Labcorp, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 13 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.

Other recent filings by van der Vaart Sandra D, EVP, Chief Legal Officer

The full history of van der Vaart Sandra D, EVP, Chief Legal Officer is on the profile page.

How this filing works

Other disclosures at Labcorp

Everything OQRO holds on this company is on its LH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data